EnlargeNovocure reader comments 9 Share this story An electric skull cap designed to zap cancer cells trying to grow in the brains of wearers proved useful at improving patient survival in a five-year clinical trial. When combined with standard chemotherapy, the cap more than doubled five-year survival rates of brain cancer patients—from 5 percent...